Skip to content

Performance of the Salt Lake Mask System

Assessment of the Performance of the Salt Lake Mask System as a Patient Interface in the Provision of Positive Airway Pressure (PAP) Therapy

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01395693
Enrollment
20
Registered
2011-07-15
Start date
2011-06-30
Completion date
2011-07-31
Last updated
2012-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Brief summary

Assessment of the performance of the Salt Lake mask system acting as a patient interface in the provision of PAP therapy. This study will assess the suitability of this mask system in its current form for use.

Detailed description

Sleep-disordered breathing (SDB) is a significant direct cause of morbidity and mortality, as well as being a significant indirect cause of morbidity and mortality impacting greatly upon health and quality of life when left untreated. Positive Airway Pressure (PAP) therapy is an effective and proven form of medical treatment for many types of SDB. In order for PAP therapy to be effective, patient interfaces(masks) need to be both effective in their delivery of this treatment and accepted by prospective and current patients for use. This study will investigate the ability of the Salt Lake mask system to act effectively as a patient interface in PAP therapy, and its ability to be accepted by patients.

Interventions

DEVICESalt Lake mask system

Study participants will Salt Lake mask system for 1 week in place of their current mask system.

Sponsors

ResMed
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients willing to give written informed consent * Patients who can read and comprehend English * Patients using the Swift FX mask system * Patients who can trial the mask for 7 nights * Patients who have used PAP therapy for a minimum of 6 months.

Exclusion criteria

* Patients not willing to give written informed consent * Patients who can not read and comprehend English * Patients using an inappropriate mask system * Patients using Bilevel flow generators * Patients who are pregnant * Patients who are unable to comply with the protocol * Patients who have used PAP therapy for less than 6 months.

Design outcomes

Primary

MeasureTime frameDescription
Subjectively Assessed Levels of Seal, Comfort, Stability and Overall Performance.1 weekParticipants in the study will complete a subjective assessment of the levels of seal, comfort, stability and overall Performance of Salt Lake Mask System in use.

Secondary

MeasureTime frameDescription
Subjective Assessments of Ease and Intuitiveness in Assembly and Disassembly1 weekParticipants in the study will subjectively assess the ease and intuitiveness of specific common assembly/diosassembly tasks related to the Salt Lake mask system.
Subjectively Assessed Levels of Skin Markings1 weekParticipants in the study will subjectively assess the levels of Skin Markings experienced as a direct result of use of the Salt Lake mask system.

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026